Sunday, September 13, 2026
ExploreSearch
Via News
MarketCommodities

Palladium Futures Is 14% Down In The Last 21 Sessions

Palladium Futures Is 14% Down In The Last 21 Sessions

(VIANEWS) - Palladium (PA) has been up by 14.15% for the last 21 sessions. At 23:54 EST on Friday, 2 June, Palladium (PA) is $1,374.00.

Volume

Today's last reported volume for Palladium is 1664, 99.99% below its average volume of 4797690323.92.

Volatility

Palladium's last week, last month's, and last quarter's current intraday variation average was a negative 0.61%, a negative 0.44%, and a positive 2.06%, respectively.

Palladium's highest amplitude of average volatility was 1.60% (last week), 1.88% (last month), and 2.06% (last quarter), respectively.

More news about Palladium (PA).

Categories

MarketCommodities

Tags

CommodityCommoditiesFuturesPAPalladiumPrice DownCommodities Price DownCommodities Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com